Skip to main content
SpringerLink
Log in

Adalimumab/rifampicin

Leukocytoclastic vasculitis and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cancado GGL, et al. Adalimumab-induced leukocytoclastic vasculitis in a Crohn's disease patient. European Journal of Gastroenterology and Hepatology 33: 453, No. 3, Mar 2021. Available from: URL: http://doi.org/10.1097/MEG.0000000000001945

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/rifampicin. Reactions Weekly 1873, 20 (2021). https://doi.org/10.1007/s40278-021-02443-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-02443-4

Search

Navigation